Fate Therapeutics Selected for Four Presentations Highlighting its Off-the-Shelf CAR T-Cell Portfolio in Autoimmune Disease at ACR Convergence 2026Globe Newswire•16/09/2026•07:00 ET0 ShareWhiz InsightsGenerateNo content available.
